S. Kazama

24.6k total citations
103 papers, 1.3k citations indexed

About

S. Kazama is a scholar working on Mechanical Engineering, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, S. Kazama has authored 103 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Mechanical Engineering, 34 papers in Cardiology and Cardiovascular Medicine and 22 papers in Biomedical Engineering. Recurrent topics in S. Kazama's work include Membrane Separation and Gas Transport (35 papers), Covalent Organic Framework Applications (19 papers) and Cardiovascular Function and Risk Factors (14 papers). S. Kazama is often cited by papers focused on Membrane Separation and Gas Transport (35 papers), Covalent Organic Framework Applications (19 papers) and Cardiovascular Function and Risk Factors (14 papers). S. Kazama collaborates with scholars based in Japan, United States and United Kingdom. S. Kazama's co-authors include Shuhong Duan, Teruhiko Kai, Ikuo Taniguchi, Kenji Haraya, Hidetaka Yamada, Takayuki Higashii, Yoichi Matsuzaki, Takashi Teramoto, Kôichi Yamada and Yuichi Fujioka and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Physical Chemistry B and Chemical Communications.

In The Last Decade

S. Kazama

91 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Kazama Japan 21 833 322 291 237 194 103 1.3k
Hakuai Inoue Japan 21 653 0.8× 543 1.7× 467 1.6× 162 0.7× 36 0.2× 106 1.6k
Mario Mariani Italy 23 237 0.3× 596 1.9× 113 0.4× 100 0.4× 164 0.8× 136 1.9k
Shigeo Goto Japan 28 659 0.8× 1.3k 4.1× 884 3.0× 373 1.6× 67 0.3× 274 3.1k
Manuel Maréchal France 21 93 0.1× 250 0.8× 353 1.2× 745 3.1× 281 1.4× 58 1.4k
Satoshi Nakao Japan 26 200 0.2× 510 1.6× 618 2.1× 588 2.5× 108 0.6× 127 2.4k
Fen Liu China 18 128 0.2× 498 1.5× 144 0.5× 292 1.2× 87 0.4× 99 1.5k
Peter Gray Australia 18 361 0.4× 431 1.3× 230 0.8× 73 0.3× 12 0.1× 57 1.0k
Naoto Ohmura Japan 18 212 0.3× 131 0.4× 417 1.4× 116 0.5× 28 0.1× 132 1.1k
Zhen Chen China 30 443 0.5× 1.7k 5.2× 165 0.6× 438 1.8× 35 0.2× 95 2.3k

Countries citing papers authored by S. Kazama

Since Specialization
Citations

This map shows the geographic impact of S. Kazama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kazama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kazama more than expected).

Fields of papers citing papers by S. Kazama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kazama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kazama. The network helps show where S. Kazama may publish in the future.

Co-authorship network of co-authors of S. Kazama

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kazama. A scholar is included among the top collaborators of S. Kazama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kazama. S. Kazama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morimoto, Ryota, S. Kazama, Hiroaki Hiraiwa, et al.. (2025). Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and Pertuzumab. Circulation Reports. 7(9). 800–808. 1 indexed citations
2.
Hiraiwa, Hiroaki, Ryota Ito, S. Kazama, et al.. (2025). Ability of dynamic chest radiography to identify left ventricular systolic dysfunction in heart failure. The International Journal of Cardiovascular Imaging. 41(3). 507–521.
3.
4.
Hiraiwa, Hiroaki, Ryota Ito, S. Kazama, et al.. (2025). Clinical utility of dynamic chest radiography in the oblique view to evaluate cardiac contraction: a case description. Quantitative Imaging in Medicine and Surgery. 15(3). 2632–2641.
5.
Kondo, Toru, Tomo Yoshizumi, Ryota Morimoto, et al.. (2024). Predicting Survival After Impella Implantation in Patients with Cardiogenic Shock: The J-PVAD Risk Score. European Journal of Heart Failure. 27(1). 51–59. 5 indexed citations
6.
Hiraiwa, Hiroaki, Ryota Ito, Yuichiro Koyama, et al.. (2024). Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan. Journal of Artificial Organs. 28(1). 83–89.
7.
Shimizu, Miho, Hiroaki Hiraiwa, Shinya Tanaka, et al.. (2023). Cardiac Rehabilitation in Severe Heart Failure Patients with Impella 5.0 Support via the Subclavian Artery Approach Prior to Left Ventricular Assist Device Implantation. Journal of Personalized Medicine. 13(4). 630–630. 3 indexed citations
8.
Hasegawa, Tomoya, et al.. (2023). Development of a low-noise SiPM for the DARWIN experiment. 1435–1435. 1 indexed citations
9.
Hiraiwa, Hiroaki, Ryota Morimoto, Ryota Ando, et al.. (2022). Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsy. Journal of Cardiology Cases. 26(1). 62–65. 9 indexed citations
10.
Araki, Takashi, Takahiro Okumura, Hiroaki Hiraiwa, et al.. (2022). Serum Autotaxin as a Novel Prognostic Marker in Patients with Non-Ischaemic Dilated Cardiomyopathy. ESC Heart Failure. 9(2). 1304–1313. 5 indexed citations
11.
Kazama, S., Toru Kondo, Naoki Shibata, et al.. (2021). Clinical Impact of Heart Rate Change in Patients with Acute Heart Failure in the Early Phase. ESC Heart Failure. 8(4). 2982–2990. 1 indexed citations
12.
Kazama, S., Ryota Morimoto, Yuki Kimura, et al.. (2021). Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review. Cardio-Oncology. 7(1). 26–26. 4 indexed citations
13.
Morimoto, Ryota, Takashi Mizutani, Takashi Araki, et al.. (2021). Prognostic Value of Resting Cardiac Power Index Depends on Mean Arterial Pressure in Dilated Cardiomyopathy. ESC Heart Failure. 8(4). 3206–3213. 5 indexed citations
14.
Okumura, Takahiro, Hiroaki Hiraiwa, Takashi Araki, et al.. (2020). Two cases of dilated cardiomyopathy with blood pressure-limited tolerability of cardioprotective agents improved by ivabradine. Journal of Cardiology Cases. 23(4). 149–153. 2 indexed citations
15.
Oishi, Hideo, Toru Kondo, Kazuro Fujimoto, et al.. (2020). Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device. Journal of Artificial Organs. 23(4). 378–382. 7 indexed citations
16.
Kondo, Toru, Sumio Yamada, S. Kazama, et al.. (2019). Neuromuscular Electrical Stimulation is Feasible in Patients with Acute Heart Failure. ESC Heart Failure. 6(5). 975–982. 15 indexed citations
17.
Taniguchi, Ikuo, Teruhiko Kai, Shuhong Duan, S. Kazama, & Hiroshi Jinnai. (2014). Development of CO2 Separation Membrane with Poly(amido amine) Dendrimer. KOBUNSHI RONBUNSHU. 71(5). 202–210. 1 indexed citations
18.
19.
Kazama, S., et al.. (2010). Development of Scratch Inspection System for Cylindrical Products by Image Processing. Journal of the Japan Society for Precision Engineering. 76(8). 955–959. 2 indexed citations
20.
Kazama, S.. (2006). CO<sub>2</sub> Separation Membrane. MEMBRANE. 31(1). 6–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakuai Inoue Breakdown of academic impact, for papers by Mario Mariani Breakdown of academic impact, for papers by Shigeo Goto Breakdown of academic impact, for papers by Manuel Maréchal Breakdown of academic impact, for papers by Satoshi Nakao Breakdown of academic impact, for papers by Fen Liu Breakdown of academic impact, for papers by Peter Gray Breakdown of academic impact, for papers by Naoto Ohmura Breakdown of academic impact, for papers by Zhen Chen
Rankless by CCL
2026